RTS,S/AS01 malaria vaccine (Mosquirix®): a profile of its use
RTS,S/AS01 malaria vaccine (Mosquirix®): a profile of its use
About this item
Full title
Author / Creator
Publisher
Cham: Springer International Publishing
Journal title
Language
English
Formats
Publication information
Publisher
Cham: Springer International Publishing
Subjects
More information
Scope and Contents
Contents
RTS,S/AS01 (Mosquirix
®
) is a vaccine against malaria caused by
Plasmodium falciparum
. In a phase 3 trial, RTS,S/AS01 showed vaccine efficacy against clinical malaria, severe malaria and malaria hospitalization, with an acceptable safety and tolerability profile, in children aged 6 weeks to 17 months; the vaccine efficacy was greater...
Alternative Titles
Full title
RTS,S/AS01 malaria vaccine (Mosquirix®): a profile of its use
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9449949
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9449949
Other Identifiers
ISSN
1172-0360
E-ISSN
1179-1977
DOI
10.1007/s40267-022-00937-3
